Insider Buying: UnitedHealth Group Incorporated (NYSE:UNH) Director Buys 300 Shares of Stock
UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) Director John H. Noseworthy purchased 300 shares of the firm’s stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. This represents a 5.21% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
UnitedHealth Group Stock Up 6.2%
UnitedHealth Group stock opened at $291.24 on Friday. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The firm has a 50 day moving average price of $470.82 and a 200-day moving average price of $513.95. The company has a market capitalization of $264.20 billion, a P/E ratio of 18.79, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the company earned $6.91 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 35.18%.
Analysts Set New Price Targets
Several equities research analysts have weighed in on UNH shares. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research note on Wednesday. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating for the company in a research report on Wednesday. KeyCorp decreased their target price on shares of UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a research report on Thursday. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 22nd. Six equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $486.00.
Institutional Trading of UnitedHealth Group
A number of institutional investors have recently modified their holdings of UNH. Financial Management Professionals Inc. lifted its stake in UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after purchasing an additional 17 shares in the last quarter. Western Pacific Wealth Management LP lifted its stake in UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after purchasing an additional 19 shares in the last quarter. MCF Advisors LLC lifted its stake in UnitedHealth Group by 0.8% in the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock worth $1,304,000 after purchasing an additional 20 shares in the last quarter. Axiom Financial Strategies LLC increased its holdings in shares of UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after buying an additional 20 shares during the last quarter. Finally, Richwood Investment Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after buying an additional 20 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Company Profile
(Get Free Report)UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Source link
